An evaluation of overall survival in patients with newly diagnosed acute myeloid leukemia and the relationship with glasdegib treatment and exposure Swan LinNaveed ShaikAna Ruiz-Garcia Original Article Open access 03 September 2020 Pages: 451 - 459
Physiologically based pharmacokinetic modeling to assess metabolic drug–drug interaction risks and inform the drug label for fedratinib Fan WuGopal KrishnaSekhar Surapaneni Original Article Open access 04 September 2020 Pages: 461 - 473
Population pharmacokinetic analysis of nanoparticle-bound and free camptothecin after administration of NLG207 in adults with advanced solid tumors Keith T. SchmidtAlwin D. R. HuitemaWilliam D. Figg Original Article Open access 08 September 2020 Pages: 475 - 486
Pharmacokinetic and pharmacodynamic analysis of neutropenia following nab-paclitaxel administration in Japanese patients with metastatic solid cancer Takahiro TsushimaHidefumi KasaiYusuke Tanigawara Original Article 15 September 2020 Pages: 487 - 495
Nivolumab increases pulmonary artery pressure in patients treated for non-small cell lung cancer Ludovic FournelPascaline Boudou-RouquetteMarco Alifano Original Article 16 September 2020 Pages: 497 - 505
Drug interactions with Bruton’s tyrosine kinase inhibitors: clinical implications and management Karen M. FancherJeremy J. Pappacena Original Article 17 September 2020 Pages: 507 - 515
Efficacy of EGFR tyrosine kinase inhibitors in patients having EGFR-activating mutations with or without BIM polymorphisms Ryo AriyasuNoriko YanagitaniMakoto Nishio Original Article 18 September 2020 Pages: 517 - 525
CYP17A1 polymorphism c.-362T>C predicts clinical outcome in metastatic castration-resistance prostate cancer patients treated with abiraterone Stefania CrucittaMarzia Del ReRomano Danesi Original Article 18 September 2020 Pages: 527 - 533
Evaluation of the pharmacokinetic drug-drug interaction potential of iohexol, a renal filtration marker Anand JoshiJianxia GuoJan H. Beumer Original Article 18 September 2020 Pages: 535 - 545
Ibudilast for prevention of oxaliplatin-induced acute neurotoxicity: a pilot study assessing preliminary efficacy, tolerability and pharmacokinetic interactions in patients with metastatic gastrointestinal cancer Christina TengStephanie E. ReuterJanette L. Vardy Original Article 19 September 2020 Pages: 547 - 558
Population pharmacokinetics and renal toxicity of cisplatin in cancer patients with renal dysfunction Tomoko Morita-OgawaHiroki SugitaKazuhiko Hanada Original Article 19 September 2020 Pages: 559 - 566
A phase I, randomized, single-dose pharmacokinetic study comparing sb8 (bevacizumab biosimilar) with reference bevacizumab in healthy volunteers Donghoon ShinYoon Jung LeeMagdalena Petkova Clinical Trial Report Open access 19 September 2020 Pages: 567 - 575